Table of Contents
Executive Summary
1 Industry Overview of Irritable Bowel Syndrome (IBS) Therapeutics
1.1 Definition of Irritable Bowel Syndrome (IBS) Therapeutics
1.2 Irritable Bowel Syndrome (IBS) Therapeutics Segment by Type
1.2.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Blautix (Strain)
1.2.3 Bekinda (IBS-D)
1.2.4 SYN-010
1.2.5 Tenapanor
1.3 Irritable Bowel Syndrome (IBS) Therapeutics Segment by Applications
1.3.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Research
1.4 Global Irritable Bowel Syndrome (IBS) Therapeutics Overall Market
1.4.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue (2014-2025)
1.4.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Production (2014-2025)
1.4.3 North America Irritable Bowel Syndrome (IBS) Therapeutics Status and Prospect (2014-2025)
1.4.4 Europe Irritable Bowel Syndrome (IBS) Therapeutics Status and Prospect (2014-2025)
1.4.5 China Irritable Bowel Syndrome (IBS) Therapeutics Status and Prospect (2014-2025)
1.4.6 Japan Irritable Bowel Syndrome (IBS) Therapeutics Status and Prospect (2014-2025)
1.4.7 Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Status and Prospect (2014-2025)
1.4.8 India Irritable Bowel Syndrome (IBS) Therapeutics Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Irritable Bowel Syndrome (IBS) Therapeutics
2.3 Manufacturing Process Analysis of Irritable Bowel Syndrome (IBS) Therapeutics
2.4 Industry Chain Structure of Irritable Bowel Syndrome (IBS) Therapeutics
3 Development and Manufacturing Plants Analysis of Irritable Bowel Syndrome (IBS) Therapeutics
3.1 Capacity and Commercial Production Date
3.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Irritable Bowel Syndrome (IBS) Therapeutics
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Irritable Bowel Syndrome (IBS) Therapeutics Production and Capacity Analysis
4.2 Irritable Bowel Syndrome (IBS) Therapeutics Revenue Analysis
4.3 Irritable Bowel Syndrome (IBS) Therapeutics Price Analysis
4.4 Market Concentration Degree
5 Irritable Bowel Syndrome (IBS) Therapeutics Regional Market Analysis
5.1 Irritable Bowel Syndrome (IBS) Therapeutics Production by Regions
5.1.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Production by Regions
5.1.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Regions
5.2 Irritable Bowel Syndrome (IBS) Therapeutics Consumption by Regions
5.3 North America Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis
5.3.1 North America Irritable Bowel Syndrome (IBS) Therapeutics Production
5.3.2 North America Irritable Bowel Syndrome (IBS) Therapeutics Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Irritable Bowel Syndrome (IBS) Therapeutics Import and Export
5.4 Europe Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis
5.4.1 Europe Irritable Bowel Syndrome (IBS) Therapeutics Production
5.4.2 Europe Irritable Bowel Syndrome (IBS) Therapeutics Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Irritable Bowel Syndrome (IBS) Therapeutics Import and Export
5.5 China Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis
5.5.1 China Irritable Bowel Syndrome (IBS) Therapeutics Production
5.5.2 China Irritable Bowel Syndrome (IBS) Therapeutics Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Irritable Bowel Syndrome (IBS) Therapeutics Import and Export
5.6 Japan Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis
5.6.1 Japan Irritable Bowel Syndrome (IBS) Therapeutics Production
5.6.2 Japan Irritable Bowel Syndrome (IBS) Therapeutics Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Irritable Bowel Syndrome (IBS) Therapeutics Import and Export
5.7 Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis
5.7.1 Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Production
5.7.2 Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Import and Export
5.8 India Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis
5.8.1 India Irritable Bowel Syndrome (IBS) Therapeutics Production
5.8.2 India Irritable Bowel Syndrome (IBS) Therapeutics Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Irritable Bowel Syndrome (IBS) Therapeutics Import and Export
6 Irritable Bowel Syndrome (IBS) Therapeutics Segment Market Analysis (by Type)
6.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Production by Type
6.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Type
6.3 Irritable Bowel Syndrome (IBS) Therapeutics Price by Type
7 Irritable Bowel Syndrome (IBS) Therapeutics Segment Market Analysis (by Application)
7.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Consumption by Application
7.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Consumption Market Share by Application (2014-2019)
8 Irritable Bowel Syndrome (IBS) Therapeutics Major Manufacturers Analysis
8.1 Abbott Laboratories
8.1.1 Abbott Laboratories Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
8.1.2 Abbott Laboratories Product Introduction, Application and Specification
8.1.3 Abbott Laboratories Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Synergy Pharmaceuticals
8.2.1 Synergy Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
8.2.2 Synergy Pharmaceuticals Product Introduction, Application and Specification
8.2.3 Synergy Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Sucampo Pharmaceuticals
8.3.1 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
8.3.2 Sucampo Pharmaceuticals Product Introduction, Application and Specification
8.3.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Valeant Pharmaceuticals International
8.4.1 Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
8.4.2 Valeant Pharmaceuticals International Product Introduction, Application and Specification
8.4.3 Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Ardelyx
8.5.1 Ardelyx Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
8.5.2 Ardelyx Product Introduction, Application and Specification
8.5.3 Ardelyx Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Astellas Pharma
8.6.1 Astellas Pharma Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
8.6.2 Astellas Pharma Product Introduction, Application and Specification
8.6.3 Astellas Pharma Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Novartis
8.7.1 Novartis Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
8.7.2 Novartis Product Introduction, Application and Specification
8.7.3 Novartis Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 GlaxoSmithKline
8.8.1 GlaxoSmithKline Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
8.8.2 GlaxoSmithKline Product Introduction, Application and Specification
8.8.3 GlaxoSmithKline Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Ironwood Pharmaceuticals
8.9.1 Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
8.9.2 Ironwood Pharmaceuticals Product Introduction, Application and Specification
8.9.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
9 Development Trend of Analysis of Irritable Bowel Syndrome (IBS) Therapeutics Market
9.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Trend Analysis
9.1.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size (Volume and Value) Forecast 2019-2025
9.2 Irritable Bowel Syndrome (IBS) Therapeutics Regional Market Trend
9.2.1 North America Irritable Bowel Syndrome (IBS) Therapeutics Forecast 2019-2025
9.2.2 Europe Irritable Bowel Syndrome (IBS) Therapeutics Forecast 2019-2025
9.2.3 China Irritable Bowel Syndrome (IBS) Therapeutics Forecast 2019-2025
9.2.4 Japan Irritable Bowel Syndrome (IBS) Therapeutics Forecast 2019-2025
9.2.5 Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Forecast 2019-2025
9.2.6 India Irritable Bowel Syndrome (IBS) Therapeutics Forecast 2019-2025
9.3 Irritable Bowel Syndrome (IBS) Therapeutics Market Trend (Product Type)
9.4 Irritable Bowel Syndrome (IBS) Therapeutics Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Irritable Bowel Syndrome (IBS) Therapeutics Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
【掲載企業】
Abbott Laboratories、Synergy Pharmaceuticals、Sucampo Pharmaceuticals、Valeant Pharmaceuticals International、Ardelyx、Astellas Pharma、Novartis、GlaxoSmithKline、Ironwood Pharmaceuticals
【免責事項】
https://www.globalresearch.jp/disclaimer